Correlation of Tumor Necrosis Factor Receptor-1 (TNFR1) with the Degree of Nephropathy in Diabetic Type 2 Patients
DOI:
https://doi.org/10.46966/msjar.v5i3.201Keywords:
TNFR1, T2DM, Nephropathy, AlbuminuriaAbstract
Background: Diabetes Mellitus (DM) is chronic metabolic disorder described by defects in action or secretion of insulin or both lead to hyperglycemia, the chronic diabetes hyperglycemia is related with dysfunction, failure and long-term damage of different organs. Type II diabetes mellitus (TIIDM) is a highly prevalent disease with a hereditary basis and the intervention of environmental risk factors, particularly bad lifestyle practices that lead to overweight and obesity. Diabetes mellitus is one of the world's most serious public health issues. Diabetic patients have a high morbidity and mortality rate as a result of the development of various diabetic complications, including nephropathy, vasculopathy, cardiomyopathy, retinopathy, and neuropathy. Diabetic nephropathy is a complication of diabetes that affects approximately 40% of diabetic patients. Diabetic nephropathy, a primary cause of end-stage renal disease (ESRD), affects 30–40% of patients who require maintenance dialysis, putting an additional burden on healthcare systems. The present study was mainly aimed to the correlation TNF-receptor 1 , in serum as markers for primary detection of degree DN in a sample of Iraqi patients having type two diabetes mellitus (T2DM). Between August 2023 and January 2024, a grand total of 120 patients with type II DM were investigated. patients were selected from the Center of Diabetes and Endocrinology in Al-Sader Teaching Hospital in Najaf city were enrolled in this study. The patients were divided into three groups based on their albumin-to-creatinine ratio (ACR): normoalbuminuria, microalbuminuria, and macroalbuminuria. All participants underwent clinical evaluation along with a range of tests such as blood pressure, weight and height measurements, blood tests fasting blood sugar (FBS), glycated hemoglobin (HbA1c), serum urea and creatinine in addition to albumin and creatinine in urine. TNFR1 were measured by ELISA technique. The prevalence of microalbuminuria and macroalbuminuria was 63.29% and 11.10% respectively in the group of patients in this research. This implies that diabetic nephropathy is present in about 74.39% of the diabetic populations in this research.
Conclusion: Based on the result of this study a significantly high concentrations of TNF receptor 1 were discovered in diabetic patients with macroalbuminuria and microalbuminuria compared to diabetic groups with normoalbuminurin. TNFR receptor 1 was found No correlating with the age,gender urine creatinine and HbA1c.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Wafaa Nouri Yassin AL-Husseini , Kareem Galia Mohamed

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















